JP2022504650A5 - - Google Patents

Info

Publication number
JP2022504650A5
JP2022504650A5 JP2021519763A JP2021519763A JP2022504650A5 JP 2022504650 A5 JP2022504650 A5 JP 2022504650A5 JP 2021519763 A JP2021519763 A JP 2021519763A JP 2021519763 A JP2021519763 A JP 2021519763A JP 2022504650 A5 JP2022504650 A5 JP 2022504650A5
Authority
JP
Japan
Prior art keywords
compound
phenyl
oxazole
chlorobenzo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021519763A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504650A (ja
JP7503850B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055493 external-priority patent/WO2020077024A1/en
Publication of JP2022504650A publication Critical patent/JP2022504650A/ja
Publication of JP2022504650A5 publication Critical patent/JP2022504650A5/ja
Application granted granted Critical
Publication of JP7503850B2 publication Critical patent/JP7503850B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021519763A 2018-10-10 2019-10-10 シャペロン介在性オートファジー調節剤として有用なベンゾオキサゾールおよび関連化合物 Active JP7503850B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743920P 2018-10-10 2018-10-10
US62/743,920 2018-10-10
PCT/US2019/055493 WO2020077024A1 (en) 2018-10-10 2019-10-10 Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators

Publications (3)

Publication Number Publication Date
JP2022504650A JP2022504650A (ja) 2022-01-13
JP2022504650A5 true JP2022504650A5 (cg-RX-API-DMAC7.html) 2022-10-03
JP7503850B2 JP7503850B2 (ja) 2024-06-21

Family

ID=70163886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519763A Active JP7503850B2 (ja) 2018-10-10 2019-10-10 シャペロン介在性オートファジー調節剤として有用なベンゾオキサゾールおよび関連化合物

Country Status (11)

Country Link
US (1) US12473266B2 (cg-RX-API-DMAC7.html)
EP (1) EP3863755A4 (cg-RX-API-DMAC7.html)
JP (1) JP7503850B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210082466A (cg-RX-API-DMAC7.html)
CN (1) CN113195084B (cg-RX-API-DMAC7.html)
AU (1) AU2019358074A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021006843A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115297A1 (cg-RX-API-DMAC7.html)
IL (1) IL282069A (cg-RX-API-DMAC7.html)
MX (1) MX2021004134A (cg-RX-API-DMAC7.html)
WO (1) WO2020077024A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022015624A1 (en) * 2020-07-16 2022-01-20 Schrödinger, Inc. Substituted dihydropyrazinediones as modulators of the nmda receptor
JP2023551435A (ja) * 2020-11-20 2023-12-08 エフ. ホフマン-ラ ロシュ アーゲー B型肝炎ウイルス感染症の処置及び予防のためのn置換4-(1,3-アリールオキサゾロ-2-イル)フェニル化合物
WO2022155333A1 (en) * 2021-01-13 2022-07-21 Albert Einstein College Of Medicine Use of chaperone-mediated autophagy activators for treating or preventing blood cancers and myelodysplastic syndromes
EP4326267A4 (en) * 2021-04-21 2025-07-09 Albert Einstein College Medicine METHOD FOR INCREASING CHAPERONE-MEDIATED AUTOPHAGY BY STABILIZING THE INTERACTION BETWEEN THE RETINOIC ACID RECEPTOR ALPHA AND AN INHIBITOR
KR102778740B1 (ko) 2021-06-24 2025-03-07 주식회사 엘지화학 합성가스의 제조방법
CN114404421B (zh) * 2022-02-28 2023-04-28 同济大学 选择性自噬激活剂qx77在制备干预或治疗糖尿病视网膜病变的药物中的应用
WO2024225738A1 (ko) * 2023-04-25 2024-10-31 부산대학교 산학협력단 지방간질환 치료 또는 예방 목적의 fxr/ppar alpha 이중 작용 활성을 가지는 벤즈옥사졸 유도체 화합물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH469802A (de) * 1966-01-07 1969-03-15 Ciba Geigy Verwendung von Benzoxazol-Derivaten als Scintillator-Substanzen
US5428052A (en) * 1984-09-19 1995-06-27 Centre Internationale De Recherches Dermatologiques (C.I.R.D.) Aromatic heterocyclic derivatives and their therapeutic and cosmetic use
ATE240942T1 (de) * 1995-11-17 2003-06-15 Merck & Co Inc Neue substituierte aryl-verbindungen als acetylcholine receptors modulatoren
AU2002365892A1 (en) * 2001-11-30 2003-06-17 Merck & Co., Inc. Metabotropic glutamate receptor-5 modulators
KR20040096601A (ko) 2002-02-21 2004-11-16 시바 스페셜티 케미칼스 홀딩 인크. 락탐계 안료 및 착색된 플라스틱 또는 중합체성 착색입자의 제조시 이의 용도
JP4903133B2 (ja) 2004-04-30 2012-03-28 ジェネンテック,インコーポレイティド ヘッジホッグシグナル伝達のキノキサリン阻害剤
UA91341C2 (ru) * 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
EP1954287B2 (en) 2005-10-31 2016-02-24 Merck Sharp & Dohme Corp. Cetp inhibitors
BRPI0707719A2 (pt) * 2006-02-10 2011-05-10 Summit Corp Plc uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo
GB0602768D0 (en) * 2006-02-10 2006-03-22 Vastox Plc Treatment of muscular dystrophy
RU2462458C2 (ru) * 2006-02-10 2012-09-27 Байомарин Ига Лимитед Лечение миодистрофии дюшена
AR066879A1 (es) 2007-06-08 2009-09-16 Novartis Ag Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
AU2008285289A1 (en) 2007-08-03 2009-02-12 Biomarin Iga Limited Drug combinations for the treatment of Duchenne muscular dystrophy
MX2011002647A (es) 2008-09-23 2011-04-07 Wista Lab Ltd Ligandos para moleculas tau agregadas.
JP2011168515A (ja) 2010-02-17 2011-09-01 Kowa Co エリスロポエチン産生促進作用を有する2−アリールベンゾオキサゾール化合物
US9512092B2 (en) * 2013-12-12 2016-12-06 Albert Einstein College Of Medicine, Inc. Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
EP3187495A1 (en) * 2015-12-30 2017-07-05 Johannes Gutenberg-Universität Mainz 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment
EP3431472B1 (en) * 2016-03-17 2023-05-03 Checkmate Therapeutics Inc. Novel compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
JP2018087173A (ja) 2016-11-29 2018-06-07 国立大学法人北海道大学 悪性脳腫瘍治療薬
US10308644B2 (en) 2016-12-22 2019-06-04 Incyte Corporation Heterocyclic compounds as immunomodulators
US10676467B2 (en) 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof

Similar Documents

Publication Publication Date Title
AU2016299485B2 (en) 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same
US8436038B2 (en) Indole and indazole compounds as an inhibitor of cellular necrosis
AU2009330686B2 (en) Compounds for the treatment of cancer
RU2419624C2 (ru) Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2
JP2010540462A5 (cg-RX-API-DMAC7.html)
CN109803967A (zh) 二氢嘧啶类化合物及其制备方法和用途
AR066424A1 (es) Inhibidores de proteina activada de la 5- lipoxigenasa ( flap)
JP2013510884A5 (cg-RX-API-DMAC7.html)
JP2016509591A5 (cg-RX-API-DMAC7.html)
HRP20140970T1 (hr) Spoj azolkarboksamida ili njegova sol
JP2015502335A5 (cg-RX-API-DMAC7.html)
JP2009502948A5 (cg-RX-API-DMAC7.html)
JP2014517808A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)
JPWO2023042879A5 (cg-RX-API-DMAC7.html)
JP2015524483A5 (cg-RX-API-DMAC7.html)
HRP20151336T1 (hr) Tetrahidroizokinolin-1-on derivat ili njegova sol
JP2010536750A5 (cg-RX-API-DMAC7.html)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
JP2016534984A5 (cg-RX-API-DMAC7.html)
JP2022500472A5 (cg-RX-API-DMAC7.html)
JP2013537913A5 (cg-RX-API-DMAC7.html)
KR101511771B1 (ko) 세포괴사 저해제로서의 인돌 및 인다졸 화합물
JP2007510629A5 (cg-RX-API-DMAC7.html)
JP2021534254A5 (ja) 心臓弁疾患を治療するための医薬組成物